Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

13.54 +0.56 (+4.31%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 Next >
7 Safe High-Yield Dividend Stocks to Buy in June 2023
While it’s extremely difficult to have your cake and eat it too, these top safe high-yield dividend stocks may accomplish just that. 
Via InvestorPlace
Check Out 3 High-Yielding Dividend Stocks In Consumer Staples Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Jenny Craig Loses All Its Weight, Confirms Closure After 40 Years: Who Benefits?
Jenny Craig Inc., a once-popular weight loss and nutrition business, announced its closure after 40 years due to an inability to secure additional financing. 
Via Benzinga
Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
11 Stocks: 9 Dividend Payers 2 For Growth
Not all stocks are the same, and not all stocks serve the investor’s needs. 
Via Talk Markets
Medifast: Dividend Insights
Via Benzinga
Medifast Earnings Perspective: Return On Capital Employed
Via Benzinga
Friday Is Your Last Chance To Buy Medifast Before The Dividend Payout
Via Benzinga
Medifast's Return on Invested Capital Insights
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Earnings Preview For Medifast
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
Alcoa To Rally Over 35%? Here Are 10 Other Analyst Forecasts For Wednesday
Barclays boosted the price target for Bath & Body Works Inc (NYSE: BBWI) from $39 to $43. Barclays analyst Adrienne Yih maintained an Equal-Weight rating on the stock. Bath & Body Works shares fell 5%... 
Via Benzinga
Medifast: Dividend Insights
Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED). 
Via Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Medifast, Transocean, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
High Dividend 50: Medifast, Inc.
Medifast offers an excellent yield of 5.6% today, which is quite high by its own historical standards, in addition to being a great yield in comparison to the broader market. 
Via Talk Markets
7 Ridiculously Cheap Stocks Yielding 5% in 2023
Investors will get a steep margin of safety by holding cheap dividend stocks with upside potential in 2023. 
Via InvestorPlace
Got $1,000? 2 Ultra High-Yield Dividend Stocks to Get Your Hands On
These two stocks offer whopping dividend yields ranging from 5.5% to 8%. 
Via The Motley Fool
Buy This Undervalued Stock Before Everyone Else Does
The average analyst 12-month price target of the nutrition and weight loss stock works out to a mind-boggling 171% upside. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
Upgrades 
Via Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. 
Via Benzinga
These High-Yield Dividend Stocks Are Growing at Blazing Speeds
These two stocks each yield more than 5%. 
Via The Motley Fool
7 Consumer Stocks to Buy for Growth and Dividends
Knocked lower by the market's downturn, these seven consumer stocks to buy offer the opportunity for yield and long-term appreciation. 
Via InvestorPlace
7 Dividend Stocks to Buy and Hold Forever
Of 256 dividend stocks to buy and hold, we’ve got seven that you should definitely put on your watchlist for future profits. 
Via InvestorPlace
A Look Into Consumer Cyclical Sector Value Stocks
What are Value Stocks? 
Via Benzinga
$10 Million Bet On This Energy Stock? 4 Stocks Insiders Are Buying
Although US stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.